Evidence map›Paper›PMID 40643089›Full record

ArticleClinical and translational medicine2025

Advancing immune profiling in colon cancer through enhanced lipidomics of low-input samples.

Karim Pérez-Romero, Cristina Huergo-Baños, Albert Maimó-Barceló, Lucía Martín-Saíz, Teresa Ximelis, Catalina Crespí, Marco A Martínez, Paloma de la Torre, Myriam Fernández-Isart, Daniel H Lopez and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and translational medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Karim Pérez-RomeroInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Cristina Huergo-BañosDepartment of Physical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.
Albert Maimó-BarcelóInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Lucía Martín-SaízDepartment of Physical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.
Teresa XimelisInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Catalina CrespíInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Marco A MartínezInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Paloma de la TorreInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Myriam Fernández-IsartInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
Daniel H LopezInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.
José Andrés FernándezDepartment of Physical Chemistry, Faculty of Science and Technology, University of the Basque Country (UPV/EHU), Leioa, Spain.
Ramón M RodríguezInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.ORCID https://orcid.org/0000-0002-6770-5123
Gwendolyn Barceló-CoblijnInstitut d'Investigació Sanitària Illes Balears (IdISBa) - Health Research Institute of the Balearic Islands, Palma, Spain.

Funding

Basque Government IT1491-22ESF (European Social Fund)European Regional Development Fund, ERDFFundación Científica Asociación Española Contra el Cáncer INVES222995RODRFundación Jesús Gangoiti BarreraFundación Jesús Gangoiti Barrera and Grupo Multidisciplinar de MelanomaGovern Balear (Direcció General d'Innovació i Recerca)Govern de les Illes Balears FPI/2160/2018Government of the Balearic Islands ITS2023-057Institute of Health Carlos III FI20/00180Institute of Health Carlos III PI19/00002Institute of Health Carlos III PI24/00313Ministerio de Ciencia, Innovación y Universidades BES-2016-078721Ministerio de Ciencia, Innovación y Universidades PTA2022-021759-IScientific Foundation of the Spanish Association Against Cancer INVES222995RODRSustainable Tourism Tax Fund (ITS)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40643089
PMCPMC12246954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.